Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 1317

1.
2.

Correlates of Overweight and Obesity Among Adolescents With Bipolar Disorder in the National Comorbidity Survey-Adolescent Supplement (NCS-A).

Goldstein BI, Blanco C, He JP, Merikangas K.

J Am Acad Child Adolesc Psychiatry. 2016 Dec;55(12):1020-1026. doi: 10.1016/j.jaac.2016.08.010.

PMID:
27871636
3.

Prevalence and Factors Associated with Multiple Provider Episodes in Texas: An Epidemiological Analysis of Prescription Drug Monitoring Program Data.

Ferries EA, Gilson AM, Aparasu RR, Chen H, Johnson ML, Fleming ML.

Pain Med. 2016 Oct 15. pii: pnw250. [Epub ahead of print]

PMID:
27744401
4.

[Prevalence of psychiatric and substance use disorders among three generations of migrants: Results from French population cohort].

Guardia D, Salleron J, Roelandt JL, Vaiva G.

Encephale. 2016 Sep 16. pii: S0013-7006(16)30181-6. doi: 10.1016/j.encep.2016.06.008. [Epub ahead of print] French.

PMID:
27644920
5.

Mental health and psychosocial support for South Sudanese refugees in northern Uganda: a needs and resource assessment.

Adaku A, Okello J, Lowry B, Kane JC, Alderman S, Musisi S, Tol WA.

Confl Health. 2016 Sep 7;10(1):18. doi: 10.1186/s13031-016-0085-6.

7.

Health Consequences of Environmental Exposures: Causal Thinking in Global Environmental Epidemiology.

Sly PD, Carpenter DO, Van den Berg M, Stein RT, Landrigan PJ, Brune-Drisse MN, Suk W.

Ann Glob Health. 2016 Jan-Feb;82(1):3-9. doi: 10.1016/j.aogh.2016.01.004. Review.

8.

[Twenty-five years of the French Addictovigilance Network (FAN)].

Micallef J, Mallaret M.

Therapie. 2016 Sep;71(4):375-8. doi: 10.1016/j.therap.2016.05.001. French.

PMID:
27296806
9.

Validation of the Alcohol, Smoking and Substance Involvement Screening Test in a low- and middle-income country cross-sectional emergency centre study.

van der Westhuizen C, Wyatt G, Williams JK, Stein DJ, Sorsdahl K.

Drug Alcohol Rev. 2016 Nov;35(6):702-709. doi: 10.1111/dar.12424.

PMID:
27247085
10.

Our future: a Lancet commission on adolescent health and wellbeing.

Patton GC, Sawyer SM, Santelli JS, Ross DA, Afifi R, Allen NB, Arora M, Azzopardi P, Baldwin W, Bonell C, Kakuma R, Kennedy E, Mahon J, McGovern T, Mokdad AH, Patel V, Petroni S, Reavley N, Taiwo K, Waldfogel J, Wickremarathne D, Barroso C, Bhutta Z, Fatusi AO, Mattoo A, Diers J, Fang J, Ferguson J, Ssewamala F, Viner RM.

Lancet. 2016 Jun 11;387(10036):2423-78. doi: 10.1016/S0140-6736(16)00579-1. Review. No abstract available.

PMID:
27174304
11.

Linking Infectious and Narcology Care (LINC) in Russia: design, intervention and implementation protocol.

Gnatienko N, Han SC, Krupitsky E, Blokhina E, Bridden C, Chaisson CE, Cheng DM, Walley AY, Raj A, Samet JH.

Addict Sci Clin Pract. 2016 May 4;11(1):10. doi: 10.1186/s13722-016-0058-5.

12.

Examining multi-session brief intervention for substance use in primary care: research methods of a randomized controlled trial.

Chambers JE, Brooks AC, Medvin R, Metzger DS, Lauby J, Carpenedo CM, Favor KE, Kirby KC.

Addict Sci Clin Pract. 2016 Apr 18;11(1):8. doi: 10.1186/s13722-016-0057-6.

13.
14.

Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.

Roberts NP, Roberts PA, Jones N, Bisson JI.

Cochrane Database Syst Rev. 2016 Apr 4;4:CD010204. doi: 10.1002/14651858.CD010204.pub2. Review.

PMID:
27040448
15.

The effects and risks associated to mephedrone and methylone in humans: A review of the preliminary evidences.

Karila L, Billieux J, Benyamina A, Lançon C, Cottencin O.

Brain Res Bull. 2016 Sep;126(Pt 1):61-67. doi: 10.1016/j.brainresbull.2016.03.005. Review.

PMID:
26995278
16.

Associations between DSM-IV mental disorders and subsequent onset of arthritis.

Aguilar-Gaxiola S, Loera G, Geraghty EM, Ton H, Lim CC, de Jonge P, Kessler RC, Posada-Villa J, Medina-Mora ME, Hu C, Fiestas F, Bruffaerts R, Kovess-Masféty V, Al-Hamzawi AO, Levinson D, de Girolamo G, Nakane Y, ten Have M, O'Neill S, Wojtyniak B, de Almeida JM, Florescu S, Haro JM, Scott KM.

J Psychosom Res. 2016 Mar;82:11-6. doi: 10.1016/j.jpsychores.2016.01.006.

PMID:
26944393
17.

Efficacy and safety of anti-epileptic drugs in patients with active convulsive seizures when no IV access is available: Systematic review and meta-analysis.

Jain P, Sharma S, Dua T, Barbui C, Das RR, Aneja S.

Epilepsy Res. 2016 May;122:47-55. doi: 10.1016/j.eplepsyres.2016.02.006. Review.

PMID:
26922313
18.

The Gap between the Knowledge and Current Practices--A Case of Tobacco Control Programs in Croatia.

Civljak M, Tudor Car L, Skara S, Oresković S.

Coll Antropol. 2015 Sep;39(3):803-8.

PMID:
26898086
19.

Risk Factors for Loss to Follow-Up among People Who Inject Drugs in a Risk Reduction Program at Karachi, Pakistan. A Case-Cohort Study.

Samo RN, Agha A, Shah SA, Altaf A, Memon A, Blevins M, Qian HZ, Vermund SH.

PLoS One. 2016 Feb 3;11(2):e0147912. doi: 10.1371/journal.pone.0147912.

20.

Sexual Dysfunction in Heroin Dependents: A Comparison between Methadone and Buprenorphine Maintenance Treatment.

Yee A, Danaee M, Loh HS, Sulaiman AH, Ng CG.

PLoS One. 2016 Jan 28;11(1):e0147852. doi: 10.1371/journal.pone.0147852.

Items per page

Supplemental Content

Loading ...
Support Center